Cargando…
Network meta-analysis of Chinese patent medicine adjuvant treatment of poststroke depression
BACKGROUND: Poststroke depression is one of the common complications of clinical cerebrovascular diseases. It is commonly seen in 3 to 6 months after the onset of stroke. The incidence rate is 22% to 75%. The patient not only has depression-related emotional symptoms, but also are accompanied by aut...
Autores principales: | Yu, Ying, Zhang, Gong, Liu, Jing, Han, Tao, Huang, Hailiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402887/ https://www.ncbi.nlm.nih.gov/pubmed/32756126 http://dx.doi.org/10.1097/MD.0000000000021375 |
Ejemplares similares
-
Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review
por: Yu, Ying, et al.
Publicado: (2020) -
A Network Meta-Analysis of the Clinical Efficacy and Safety of Commonly Used Chinese Patent Medicines in the Auxiliary Treatment of Poststroke Depression
por: Yu, Ying, et al.
Publicado: (2022) -
Complementary and alternative therapies for poststroke depression: A protocol for systematic review and network meta-analysis
por: Song, Kai, et al.
Publicado: (2020) -
Efficacy and safety of acupuncture combined with Chinese herbal medicine traditional Chinese medicine for poststroke cognitive impairment: A protocol for a systematic review and meta-analysis
por: Wang, Ying, et al.
Publicado: (2022) -
Simple acupuncture combined with fluoxetine in the treatment of poststroke depression: A protocol for systematic review and meta-analysis
por: Gong, Peng, et al.
Publicado: (2021)